跳至主要内容
临床试验/NCT03316508
NCT03316508已完成不适用

Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac Surgery

Claudia Herbst1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2017年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
81
试验地点
1
主要终点
Change of Copeptin concentrations

研究概览

简要总结

This study evaluates the relevance of Copeptin in children with congenital heart disease undergoing cardiac surgery with the need of cardiopulmonary bypass. Three blood samples are taken of each patient. The first and second sample are collected in the operation room before and after the procedure and the third sample on the first postoperative day at the intensive care unit.

详细描述

Objective:

Vasopressin is a hormone secreted by the posterior pituitary gland. Its main functions are constriction of blood vessels and reabsorption of water and thereby regulating water balance and hemodynamics of the body. Copeptin is a cleavage product in the synthesis of vasopressin and is released in equimolar amounts. Its stability makes it easier to determine the amount of vasopressin. It is known, that the use of a heart-lung machine in cardiac procedures has effects on the water balance of the body and may affect the vasopressin secretion.

The aim of this prospective clinical trial is, to figure out if copeptin would be suitable for perioperative risk evaluation in neonates and children with congenital heart disease after surgery with the use of a heart-lung machine.

Hypotheses:

The primary outcome endpoint of this study is the change in copeptin concentration perioperatively in patients with congenital heart disease, with the use of heart-lung machine.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
— 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ≤6 years of age
  • need of HLM for surgery
  • Informed consent of parents
  • not participating in other studies

排除标准

  • Preoperative ventilatory support
  • Preoperative circulatory support (ECMO, VAD)
  • Diabetes insipidus
  • Preoperative CPR
  • Preoperative shock
  • Preoperative sepsis
  • Preoperative vasopressin application

结局指标

主要结局

Change of Copeptin concentrations

时间窗: baseline and up to one day

Change of Copeptin concentrations between the baseline and first postoperative measurement

次要结局

  • Intubation(up to one day)
  • Cardiopulmonary bypass(up to one day)
  • Complexity of procedures(up to one day)
  • ICU stay(up to one day)

研究者

发起方
Claudia Herbst
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Claudia Herbst

Dr. med. univ.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验